However, the widespread expression of CD39, CD73, and purinergic receptors on immune cells, myofibroblasts, and epithelial cells complicates understanding of the mechanistic basis for purinergic and adenosine signaling during chronic inflammation, fibrosis, and tumor formation. The gene discussed is P2RX4; the disease is neoplasm.